Are Janus Kinase (JAK) Inhibitors Beneficial in the Treatment of Androgenic Alopecia?

    Fiore Casale, Katerina Yale, Natasha Atanaskova Mesinkovska
    Studysummary This article poses the question of whether Janus kinase (JAK) inhibitors are beneficial for treating androgenic alopecia, but it does not provide results or conclusions from any study.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 5

    1. Examination of Androgenetic Alopecia with Serum Biomarkers Journal of Cosmetic Dermatology · 2020
    2. New and Emerging Therapies for Alopecia Areata Drugs · 2020
    3. JAK Inhibitors for Alopecia Areata: A Systematic Review and Meta-Analysis JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology · 2019
    4. Classifications of Patterned Hair Loss: A Review Journal of Cutaneous and Aesthetic Surgery · 2016
    5. Alopecia Areata Is Driven by Cytotoxic T Lymphocytes and Is Reversed by JAK Inhibition Nature medicine · 2014

    Related research 3

    1. Are Janus Kinase (JAK) Inhibitors Beneficial in the Treatment of Androgenic Alopecia? International Journal of Dermatology · 2021
    2. Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib PubMed · 2018
    3. Tofacitinib 2% Ointment, a Topical Janus Kinase Inhibitor, for the Treatment of Alopecia Areata: A Pilot Study of 10 Patients Journal of the American Academy of Dermatology · 2017